SlideShare a Scribd company logo
1 of 6
Download to read offline
REGISTER BY FeBruary 25
                                                                                  AND SAVE $400!




                CMo Quality oversight
                   & risk ManageMent
              Managing CMOs to Deliver Your Product to Your Quality & Time Requirements
                                           April 28th – 29th, 2011, Omni Parker House Hotel, Boston MA




               Featured Presentations:                                          sPeaking FaCulty

regulatory Perspective on Quality assurance within the evolving       dhan amaria, Director, Quality Assurance,
Contract Manufacturing relationship                                   NEKTAR THERAPEUTICS
sandra roque, Director, Manufacturing QA, NOVEN PHARMACEUTICALS       rhonda Fendelet, Director, External Supply
                                                                      Integration Quality – PDMS, JANSSEN SUPPLY CHAIN
applying a risk Management system to the Contracting Process          rolf hartmann, Procurement Director,
to sustain the highest level of Quality from a CMo/sponsor            GLAXOSMITHKLINE
relationship                                                          Juanita hawkins, Vice President, Global
Caroline o’Brien, Associate Director QA Sourcing, Pharmaceutical      Quality Assurance and Compliance, CELGENE
Development, ASTRAZENECA                                              Jeff huth, Ph.d., Leader, Quality & Compliance,
                                                                      JANSSEN ALZHEIMER IMMUNOTHERAPY RESEARCH &
how overall Product lifecycle and Product Phases including            DEVELOPMENT
Commercialization Can Factor into the Contract Manufacturing          denise Mcdade, Senior Director, Quality
relationship                                                          Assurance, AMYLIN PHARMACEUTICALS
Jeff huth, Ph.d., Leader, Quality & Compliance,                       robert o’hagan, Director Quality Operations,
JANSSEN ALZHEIMER IMMUNOTHERAPY RESEARCH & DEVELOPMENT                ABBOTT BIORESEARCH CENTER
                                                                      Caroline o’Brien, Associate Director QA
                                                                      Sourcing, Pharmaceutical Development, ASTRAZENECA
             Featured Panel disCussion:                               sandra roque, Director, Manufacturing QA,
                                                                      NOVEN PHARMACEUTICALS
global Considerations and Business differences when Contracting       Prashant savle, Ph.d., Director, Sourcing,
an off-shore CMo Partner: how Close are We to a harmonized            Global Procurement, MERCK SHARPE & DOHME
standard of gMP?                                                      Michael semo, Global Sourcing Manager, Virtual
Panelists:                                                            CMC Team, ELI LILLY & COMPANY
Prashant savle, Ph.d., Director, Sourcing, Global Procurement,
MERCK SHARPE & DOHME                                                  g. sean Williams C.P.M., sCor-P,
                                                                      Associate Dir, Global Facilities Procurement,
Michael semo, Global Sourcing Manager, Virtual CMC Team,              BRISTOL-MYERS SQUIBB
ELI LILLY & COMPANY
                                                                      Janice B Wilson, Phd, Vice President
dhan amaria, Director, Quality Assurance, NEKTAR THERAPEUTICS         Corporate Quality Assurance, ELAN PHARMACEUTICALS

             To R e gister Call 866-207-6528 or visit www.exlpharma.com/ c m o
Dear Colleague,                                                                            This Summit is specifically
                                                                                           designed for C-Levels, Department
There is industry agreement that a substantial investment must be made to                  Heads, Vice Presidents, Directors
support the life-cycle of a pharmaceutical product from the developmental stage            and Managers at pharmaceutical,
to commercial production. There is also definitive data that shows in addition to          biotechnology and medical device
the FDA, regulatory bodies worldwide are becoming more and more conservative               companies from the following
with the candidates they approve for commercial access.                                    departments:


Within the contract manufacturing relationship, pharmaceutical companies are
taking the necessary steps to adjust to this changing industry trend, providing               Contract manufacturing
increased resources to ensure control and consistency in the manufacturing of
                                                                                              manufacturing Operations
their products to avoid unnecessary delays including regulatory action.
                                                                                              Regulatory Affairs
Join us April 28th - 29th where presentations dedicated to the successful CMO                 Regulatory Compliance
partnership dynamic will be shared, including best practices in management such               Validation
as quality oversight, risk management, and ensuring time requirements are met.                Compliance
The FDA has made it clear that if your name is on the label, you are responsible
                                                                                              Quality Assurance
for what’s inside the package.
                                                                                              Quality Operations
Look forward to seeing you in Boston!                                                         Quality Development
                                                                                              Outsourcing
Sincerely,                                                                                    Sourcing
                                                                                              Supply Chain
                                                                                              Operational Excellence
Matthew Millman
Senior Conference Director
mmillman@exlpharma.com




                                                                                           Sponsorship and
                                                                                           Exhibit Opportunities
                                                             OmNI PARkER
                                                             HOuSE HOTEl                   Do you want to spread the word
                                                                                           about your organization’s solutions
                                                               60 School Street            and services to potential clients who
                                                              Boston, MA 02108             attend this event? Take advantage of
                                                                P:617-227-8600             the opportunity to exhibit, present an
                                                                                           educational session, host a networking
                                                                                           event, or distribute promotional items to
                                                                                           attendees. ExL works closely with you
As you pass through the sculpted bronze doors of this luxury Boston hotel, you             to customize a package that suits all of
will be enveloped by the timeless beauty that has made the Omni Parker House               your needs.
a landmark since 1855. Experience the perfect blend of modern amenities and
historic charm at America’s oldest continuously-operating hotel. Walk to Beacon            To learn more about these opportunities,
Hill, Faneuil Hall Marketplace, Quincy Market, the Financial District, shopping and        contact Eric Morrin, Business
more. Just 2.5 miles (10-15 minutes) from Logan International Airport.                     Development Manager by calling
                                                                                           212-400-6228 or by emailing
room reservations: If you require overnight accommodations, please contact the hotel
and state that you are with ExL’s CMO Quality Oversight & Risk Management Conference for   emorrin@exlpharma.com.
information on our discounted room rates. We encourage conference participants to make
reservations by Wednesday, April 6th with our designated venue as our discounted room
rates are limited.


             To R e g i ster Call 866-207-6528 or visit www.exlpharma.com/c m o
day one – aPril 28th, 2011

                                                                   Pre-ConFerenCe WorkshoP
8:00       Registration Opens and Continental Breakfast
           is Served for Workshop Attendees

9:00       selecting a CMo Partner
	          How	Including	Quality	Early	in	the	Selection	Process	can	Ensure	a	
	          Stronger	Overall	Partnership
	          Led By: Janice	B	Wilson,	PhD,	Vice President Corporate Quality Assurance,
                   ELAN PHARMACEUTICALS
           •	 	Including	quality	in	the	selection	process	
              	          -	Transparency	and	accessibility	of	a	potential	partners’	quality	history	
              	          -	What	quality	factors	to	look	for	from	a	partner	
              	          -	What	issues	can	kill	the	deal?
           •	 Designing	quality	agreements	with	clear	criteria	that	define	the	responsibilities	of	an		
              outsourced	partner	
              		-	Identifying	the	important	deliverables	that	need	to	be	included	in	the	Quality	Agreement	
              		-	Customizing	a	Quality	Agreement	that	fits	a	specific	project	aspect		
              		-	Determining	which	types	of	agreements	to	use	–	technical	versus	quality?	What	is	the	difference?	
              		-	Modifying	a	Quality	Agreement	to	reflect	existing	regulations	and	industry	standards
*There will be a 30-minute coffee and networking break during the workshop

12:00      Lunch for Workshop Attendees / Registration
           Opens for Main Conference




          Main ConFerenCe
                                                                                                          3:00        networking & refreshment Break
1:15      Chairperson’s Welcome and Opening Remarks

                                                                                                          3:30        Case study: integrated Facilities
1:30      keynote talk: CMo                                                                                           Management outsourcing
          ManageMent strategy
                                                                                                          	           Thinking	with	the	End	in	Mind:	Driving	a	Streamlined	Global		
                                                                                                          	           Integrated	Facilities	Management	Outsourcing	Deal	from	Concept		
	         Aligning	Your	Corporate	Philosophy	and	Your	CMO	Outsourcing		                                   	           to	Implementation	
	         Strategy	to	Achieve	Business	Objectives	                                                        	           G.	Sean	Williams	C.P.M.,		SCOR-P	Associate	Dir,	Global	Facilities		
	         Juanita	Hawkins, Vice President, Global Quality Assurance and                                   	           Procurement,	BRISTOL-MYERS	SQUIBB
          Compliance, CELGENE                                                                                         •	 Evaluating	the	pros	and	cons	to	understand	whether	an	IFM	program	fits	into	your	
          •	 Gaining	internal	buy-in	and	understanding	the	risk	related	to	strategy			                                   company’s	strategic	planning
          •	 Critical	decision	making	for	internal,	external	or	hybrid	manufacturing	allocation                       •	 Building	the	appropriate	quality	and	performance	measurements	in	the	negotiation	
          •	 Clarity	for	expectations,	delegating	work	versus	responsibility,	and	control                                to	prevent	post	implementation	margin	erosion
                                                                                                                      •	 Key	drivers	of	Service	Provider	downselecting	outside	of	cost


2:15      regulatory Perspective                                                                          4:15        Communication
                                                                                                          	           The	Roadmap	for	Successful	Communication	within	a	Partnership	that	
	         Regulatory	Perspective	on	Quality	Assurance	within	the		
                                                                                                          	           Drives	Quality	Oversight	Success	
	         Evolving	Contract	Manufacturing	Relationship		
                                                                                                          	           Rhonda	Fendelet,	 Director, External Supply Integration Quality – PDMS,
	         Sandra	Roque, Director, Manufacturing QA, NOVEN PHARMACEUTICALS
                                                                                                                      JANSSEN SUPPLY CHAIN
          •	 Agency	concerns	over	business	procedures
                                                                                                                      •	 The	governance	model	and	deployment	of	Communication	Plan	
          •	 Expectations	for	both	sponsors	and	contract	sites	during	inspections	and	GMP	
                                                                                                                      •	 Clarifying	roles	&	responsibilities	within	the	relationship	to	avoid	dysfunction	
             assessments
                                                                                                                      •	 Using	metrics	and	feedback	as	the	key	performance	indicators	for	success
          •	 Best	practices	to	ensure	that	sponsors,	contract	manufacturers	and	regulatory	
             agencies	are	all	on	the	same	page
          •	 Upcoming	anticipated	guidance	for	selection	of	a	contract	facility	and		
             conducting	audits                                                                            5:00        Close of day one


                    To R e g i ster Call 866-207-6528 or visit www.exlpharma.com/c m o
day tWo – aPril 29th, 2011




                                                                                                             international Considerations
          Main ConFerenCe                                                                            11:45
                                                                                                     	
                                                                                                     	       PANEL	DISCUSSION:	Global	Considerations	and	Business	Differences		
                                                                                                     	       when	Contracting	an	Off-Shore	CMO	Partner:	How	Close	are	We	to		
9:00    Chairperson’s Day Two Welcome and                                                            	       a	Harmonized	Standard	of	GMP?
        Opening Remarks                                                                                      Panelists Include:
                                                                                                     	       Dhan	Amaria,	Director, Quality Assurance, NEKTAR THERAPEUTICS
                                                                                                     	       Prashant	S	Savle,	Ph.D.,	Director, Sourcing, Global Procurement,
9:05    lifecycle Considerations                                                                             MERCK SHARPE & DOHME
                                                                                                     	       Michael	Semo,	Global Sourcing Manager, Virtual CMC Team,
	       How	Overall	Product	Lifecycle	and	Product	Phases	Including	                                          ELI LILLY & COMPANY
	       Commercialization	Can	Factor	into	the	Contract	Manufacturing		                  	                    •	 What	are	the	differences	between	a	domestic	partner	and	an	international		
	       Relationship		                                                                                          one,	if	any?
	       Jeff	Huth,	Ph.D.,	 Leader, Quality & Compliance,                                                     •	 What	cultural	considerations	should	be	made	prior	to	commencement	of	the	
        JANSSEN ALZHEIMER IMMUNOTHERAPY RESEARCH & DEVELOPMENT                                                  partnership	and	how	do	these	affect	the	level	of	communication	and	expectations?
        Contract Manufacturing Organizations face an evolutionary dilemma in trying to                       •	 How	does	risk	acceptability	vary	between	a	sponsor	and	a	contract	partner?
        establish their business plan strategy and technical capabilities every day. While clearly
        there is a capital investment consideration in this regard, there are also key technical,
        operational, and regulatory considerations.                                                  12:30   lunch
        This	Session	will	Examine:
        •	 Elements	associated	with	pharmaceutical	product	life-cycle	as	they	relate	to	the	
           technical,	operational,	and	regulatory	issues                                             1:30    Metrics
        •	 Discussion	on	the	significance	of	the	partnerships	required	to	successfully	manage	       	       Using	KPIs	and	Operational	Excellence	to	Ensure	Quality	in	an	
           the	evolutionary	pharmaceutical	product	life-cycle                                        	       Outsourced	Supply	Chain
        •	 How	ICH	guidance	concepts	(in	particular,	ICH	Q10)	can	provide	a	platform	to	not	         	       Denise	McDade,	 Senior Director, Quality Assurance,
           only	manage	the	relationship,	but	to	enhance	it.                                                  AMYLIN PHARMACEUTICALS
                                                                                                             •	 Setting	quality	oversight	standards	that	drive	the	level	of	performance	
                                                                                                                measurement	and	data	collection
                                                                                                             •	 Building	a	corporate	culture	that	can	create	a	strategy	to	meet	the	standards	
9:45    risk Management                                                                                         necessary	for	quality	excellence
	       Applying	a	Risk	Management	System	to	Vendor	Assurance	and	Supplier	                                  •	 Adopting	risk-shared	principles	that	extend	accountability	to	a	project-wide	scope
	       Management	in	Development	
	       Caroline	O’Brien,	 Associate Director QA Sourcing, Pharmaceutical                            2:15    aPi development
        Development, ASTRAZENECA                                                                     	       Keys	for	Successful	Contract	Manufacturing	of	Biological	API’s	to	
        •	 Clearly	and	thoroughly	translating	risk	factors	for	materials,	processes	and	suppliers    	       Support	Clinical	and	Commercial	Material	
        •	 Understanding	of	Supply	Chain	and	application	of	risk	managed	supplier	auditing           	       Robert	O’Hagan,	 Director Quality Operations,
        •	 Development	and	maintenance	of	the	holistic	approach	to	Supplier	Management	                      ABBOTT BIORESEARCH CENTER
                                                                                                             •	 CMO	Selection	Considerations	
                                                                                                             •	 Successful	Business	Model	for	CMO	through	product	lifecycle	
10:30   networking & refreshment Break                                                                       •	 Quality	Agreements	and	Regulatory	Considerations


                                                                                                     3:00    Closing Panel disCussion:
11:00   spotlight session: outsourcing and                                                           	       Decommissions,	Facing	Problems,	and	Accepting	that	the	Partnership		
        Quality in latin america                                                                     	       is	Faulty	–	What	Should	be	Done	to	Minimize	the	Failure	
	       Considerations	when	Contracting	a	CMO	Partner	in	Latin	America:	                                     Featuring	Conference	Presenters
	       Regional	Benefits	&	Constraints                                                                      •	   What	are	the	initial	steps	to	be	taken	once	a	partnership	is	disconnected?
        Rolf	Hartmann,	Procurement Director, GLAXOSMITHKLINE                                                 •	   How	to	calculate	the	financial	implications	from	the	missteps	that	have	occurred?	
        •	 Examining	cost	differences	between	CMOs	in	Latin	America	and	other	Regions                        •	   Determine	what	the	consequences	are	and	if	they	can	be	fixed?
        •	 Ensuring	quality	standards	and	regulatory	requirements	are	met	and	kept	when		                    •	   What	are	the	public	and	reputational	damage	that	has	been	done?
           working	with	an	international	CMO
        •	 Latin	America	regional	snap-shot:	contracting	in	traditional	versus		
           non-traditional	countries                                                                 3:45    Close of Conference

                  To R e g i ster Call 866-207-6528 or visit www.exlpharma.com/c m o
Five Ways to register                                                                                                  RegistRation Fees FoR attending
                                                                                                                             exl’s CMo Quality oversight &
     PHOnE:                          866-207-6528                                                                            risk ManageMent ConFeRenCe:
        EMAIL:                       register@exlpharma.com
     OnLInE:                         www.exlpharma.com                                                                       Best value
                                                                                                                             REgISTER By FRIDAy, FEBRuARy 25TH AnD SAvE $400!
              FAx:                   888-221-6750
                                                                                                                              COnFEREnCE + WORkSHOP | $1795
            MAIL:                    ExL Events, Inc.
                                                                                                                                    COnFEREnCE OnLy | $1495
                                     555 8th Ave, Ste 310
                                     new york, ny 10018
                                                                                                                             early-Bird PriCing
                                                                                                                             REgISTER By FRIDAy, MARCH 25TH
                                                                                                                             TO TAkE ADvAnTAgE OF EARLy-BIRD PRICIng:

Group Discount proGram:                                                                                                       COnFEREnCE + WORkSHOP | $1995
                                                                                                                                    COnFEREnCE OnLy | $1695
save 25% Per Person When registering Four
For every three simultaneous registrations from your
company, you will receive a fourth complimentary                                                                             standard PriCing
registration to the program (must register 4 at one                                                                          REgISTER AFTER MARCH 25TH:
time). this is a savings of 25% per person.
                                                                                                                              COnFEREnCE + WORkSHOP | $2195
save 15% Per Person When registering three                                                                                          COnFEREnCE OnLy | $1895
Can only send three? You can still save 15% off of
every registration. to find out more on how you can                                                                          visit WWW.exlPharMa.CoM/CMo
take advantage of these group discounts, please call
                                                                                                                             TO VIEw OuR VAluE JuSTIfICATION DOCumENT!
866-207-6528.


Make checks payable to exl events, inc. and write code
                                                                                                                                         mEDIA PARTNERS
P742 on your check. You may also use Visa, MasterCard,
discover or american express. Payments must be received in
full 2 weeks prior to the conference.

Cancellations: if you need to cancel your registration for an
upcoming exL conference, please note the following policies
derived from the start date of the event:
  • Four weeks or more: a full refund (minus a $95
    processing fee), or a voucher to another exL event valid
    for two years from the voucher issue date
    Four weeks or less: a voucher to another exL event
    valid for two years from the voucher issue date.
  • to receive a refund or voucher, please fax your request to
    888-221-6750.
  • there will be an administrative charge of $300 to
    substitute, exchange and/or replace attendance badges
    with a colleague occurring within five business days of
    the conference.

Please Note: Speakers and agenda are subject to change without notice. In the event of a speaker cancellation,
every effort to find a suitable replacement will be made. ExL Pharma’s liability is limited to the conference registration
fee in the event of a cancellation
*The opinions of this faculty do not necessarily reflect those of the companies they represent or ExL Events, Inc.*


                         QuESTIONS? COmmENTS?
    do you have a question or comments that you would
    like to be addressed at this event? Would you like to get
    involved as a speaker or discussion leader?
    Please email Conference director, Matt Millman at
    mmillman@exlpharma.com
Fax:	           		           	         Telephone:	 	
                                                                                              	           	            	            	           	           	         	    Email:	
                                                                                              	       Zip:	            	     State:		           	           	         	     City:		
                                                                                              	           	            	            	           	           	         Address:	 	
                                                                                              	           	            	            	           	           	         	     Dept.:	
                                                                                              	           	            	            	           	           	         Company:	 	
                                                                                              	           	            	      Title:	           	           	         	    Name:		
                                 PLEASE	MENTION	PRIORITY	CODE:	P742                                               	I	wish	to	receive	email	updates	on	ExL	Pharma’s	upcoming	events
                                 New	York,	NY	10018                                                               	I’m	interested	in	marketing	opportunities	at	this	event
                                 555	8th	Avenue,	Suite	310                                                        Please	contact	me:
                                                                                                                           Yes!	Register	me	for	the	conference	only             
      	          	           	         	          	          	           Signature:	 	
                                                                                                                           Yes!	Register	me	for	the	conference	and	workshop:    
                 	           	         	          	          	         Name	on	Card:	
                                                                                                              www.exlpharma.com/cmo
                 Exp.	Date:	 	         	          	          	         Card	Number:		
                                                                                          registration@exlpharma.com
                                                                                                                                          New	York,	NY	10018
          MasterCard				Visa				Discover			Amex          	           Card	Type:		 	               888-221-6750
                                                                                                                                          555	8th	Avenue,	Suite	310
          Make	checks	payable	to	ExL	Events,	Inc.            	           	            	
                                                                                                      866-207-6528                        ExL	Events,	Inc.
          	Check		 Credit	Card                            Method	of	Payment:		
                                                                                                                                           Registration Form:
                                                                                                                              REGISTER BY FeBruary 25
                                                                                                                                        AND SAVE $400!
                           CMo Quality oversight
                              & risk ManageMent
                         Managing CMOs to Deliver Your Product to Your Quality & Time Requirements
                                                                       April 28th – 29th, 2011, Omni Parker House Hotel, Boston MA
                            Featured Presentations:                                                                                       sPeaking FaCulty
                                                                                                                                        FroM these CoMPanies
Regulatory Perspective on Quality Assurance                           How Overall Product lifecycle and Product Phases
within the Evolving Contract manufacturing                            Including Commercialization Can factor into the                   NEKTAR THERAPEUTICS           NOVEN
Relationship                                                          Contract manufacturing Relationship                                                         PHARMACEUTICALS
                                                                                                                                               MERCK
                                                                                                                                                                 ELI LILLY & COMPANY
Applying a Risk management System to the                              Global Considerations and Business Differences                     GLAXOSMITHKLINE
Contracting Process to Sustain the Highest level of                   when Contracting an Off-Shore CmO Partner: How                                            BRISTOL-MYERS SQUIBB
                                                                                                                                              CELGENE
Quality from a CmO/Sponsor Relationship                               Close are we to a Harmonized Standard of GmP?                                                    ELAN
                                                                                                                                           ASTRAZENECA            PHARMACEUTICALS
              To R e gister Call 866-207-6528 or visit www.exlpharma.com/ c m o

More Related Content

Viewers also liked

SharePoint Apps - SharePoint Day 2013
SharePoint Apps - SharePoint Day 2013SharePoint Apps - SharePoint Day 2013
SharePoint Apps - SharePoint Day 2013Raona
 
2011 Volkswagen Touareg-Evidence Manual
2011 Volkswagen Touareg-Evidence Manual2011 Volkswagen Touareg-Evidence Manual
2011 Volkswagen Touareg-Evidence ManualCourtney Boone
 
My Attitude
My AttitudeMy Attitude
My Attitudefaiqya
 
Profiling and optimizing RAM and CPU use in RMG-Py
Profiling and optimizing RAM and CPU use in RMG-PyProfiling and optimizing RAM and CPU use in RMG-Py
Profiling and optimizing RAM and CPU use in RMG-PyRichard West
 
Tutorial de Blogger
Tutorial de BloggerTutorial de Blogger
Tutorial de Bloggermaricel
 
Winserver 2012 R2 and Winserver 2012.Technet
Winserver 2012 R2 and Winserver 2012.TechnetWinserver 2012 R2 and Winserver 2012.Technet
Winserver 2012 R2 and Winserver 2012.TechnetEmilio
 
Caso picking (3)
Caso picking (3)Caso picking (3)
Caso picking (3)eliecer1234
 
Highlights from ExL Pharma’s 2nd Annual Patient Assistance Programs
Highlights from ExL Pharma’s 2nd Annual Patient Assistance ProgramsHighlights from ExL Pharma’s 2nd Annual Patient Assistance Programs
Highlights from ExL Pharma’s 2nd Annual Patient Assistance ProgramsExL Pharma
 
European Commission Seminar Lisbon April 2016, Reforms driving the Recovery
European Commission Seminar Lisbon April 2016, Reforms driving the RecoveryEuropean Commission Seminar Lisbon April 2016, Reforms driving the Recovery
European Commission Seminar Lisbon April 2016, Reforms driving the Recoverymsherlock
 
Collection sms
Collection smsCollection sms
Collection smsEtikalab
 
Portfolio Essentials: Expectation 6
Portfolio Essentials: Expectation 6Portfolio Essentials: Expectation 6
Portfolio Essentials: Expectation 6Jon Kelly
 
Portfolio Scanning for Dummies (S510)
Portfolio Scanning for Dummies (S510)Portfolio Scanning for Dummies (S510)
Portfolio Scanning for Dummies (S510)Jon Kelly
 
Highlights from ExL Pharma's 2nd Pharmaceutical Managed Markets
Highlights from ExL Pharma's  2nd Pharmaceutical Managed MarketsHighlights from ExL Pharma's  2nd Pharmaceutical Managed Markets
Highlights from ExL Pharma's 2nd Pharmaceutical Managed MarketsExL Pharma
 

Viewers also liked (18)

SharePoint Apps - SharePoint Day 2013
SharePoint Apps - SharePoint Day 2013SharePoint Apps - SharePoint Day 2013
SharePoint Apps - SharePoint Day 2013
 
2011 Volkswagen Touareg-Evidence Manual
2011 Volkswagen Touareg-Evidence Manual2011 Volkswagen Touareg-Evidence Manual
2011 Volkswagen Touareg-Evidence Manual
 
Networksecurity1 1
Networksecurity1 1 Networksecurity1 1
Networksecurity1 1
 
September 13 English 8
September 13 English 8September 13 English 8
September 13 English 8
 
My Attitude
My AttitudeMy Attitude
My Attitude
 
Profiling and optimizing RAM and CPU use in RMG-Py
Profiling and optimizing RAM and CPU use in RMG-PyProfiling and optimizing RAM and CPU use in RMG-Py
Profiling and optimizing RAM and CPU use in RMG-Py
 
Tutorial de Blogger
Tutorial de BloggerTutorial de Blogger
Tutorial de Blogger
 
Winserver 2012 R2 and Winserver 2012.Technet
Winserver 2012 R2 and Winserver 2012.TechnetWinserver 2012 R2 and Winserver 2012.Technet
Winserver 2012 R2 and Winserver 2012.Technet
 
Caso picking (3)
Caso picking (3)Caso picking (3)
Caso picking (3)
 
Highlights from ExL Pharma’s 2nd Annual Patient Assistance Programs
Highlights from ExL Pharma’s 2nd Annual Patient Assistance ProgramsHighlights from ExL Pharma’s 2nd Annual Patient Assistance Programs
Highlights from ExL Pharma’s 2nd Annual Patient Assistance Programs
 
European Commission Seminar Lisbon April 2016, Reforms driving the Recovery
European Commission Seminar Lisbon April 2016, Reforms driving the RecoveryEuropean Commission Seminar Lisbon April 2016, Reforms driving the Recovery
European Commission Seminar Lisbon April 2016, Reforms driving the Recovery
 
Global Pollution
Global PollutionGlobal Pollution
Global Pollution
 
Collection sms
Collection smsCollection sms
Collection sms
 
Portfolio Essentials: Expectation 6
Portfolio Essentials: Expectation 6Portfolio Essentials: Expectation 6
Portfolio Essentials: Expectation 6
 
3月社區居住工作坊講義(中英文)
3月社區居住工作坊講義(中英文)3月社區居住工作坊講義(中英文)
3月社區居住工作坊講義(中英文)
 
POS訪談常見問題彙整
POS訪談常見問題彙整POS訪談常見問題彙整
POS訪談常見問題彙整
 
Portfolio Scanning for Dummies (S510)
Portfolio Scanning for Dummies (S510)Portfolio Scanning for Dummies (S510)
Portfolio Scanning for Dummies (S510)
 
Highlights from ExL Pharma's 2nd Pharmaceutical Managed Markets
Highlights from ExL Pharma's  2nd Pharmaceutical Managed MarketsHighlights from ExL Pharma's  2nd Pharmaceutical Managed Markets
Highlights from ExL Pharma's 2nd Pharmaceutical Managed Markets
 

Similar to CMO Quality Oversight & Risk Management, April 2011, Boston

Pre Filled Syringes Asia Pacific
Pre Filled Syringes Asia PacificPre Filled Syringes Asia Pacific
Pre Filled Syringes Asia Pacificcallendermark
 
"10th Contract Manufacturing for Pharmaceuticals and Biotech Conference
"10th Contract Manufacturing for Pharmaceuticals and Biotech Conference"10th Contract Manufacturing for Pharmaceuticals and Biotech Conference
"10th Contract Manufacturing for Pharmaceuticals and Biotech Conferencecassie111
 
Shamisha corporate presentation 10112016
Shamisha corporate presentation   10112016Shamisha corporate presentation   10112016
Shamisha corporate presentation 10112016Nishodh Saxena Ph. D.
 
Tbi Bioprocessing Services Sept 25.08
Tbi Bioprocessing Services Sept 25.08Tbi Bioprocessing Services Sept 25.08
Tbi Bioprocessing Services Sept 25.08Thomas Wellner
 
PharmaForce 2012 Agenda
PharmaForce 2012 AgendaPharmaForce 2012 Agenda
PharmaForce 2012 AgendaAmanda Aslan
 
Resume Maria Santana
Resume Maria SantanaResume Maria Santana
Resume Maria SantanaSantana Maria
 
7th Cold Chain Distribution for Pharmaceuticals
7th Cold Chain Distribution for Pharmaceuticals7th Cold Chain Distribution for Pharmaceuticals
7th Cold Chain Distribution for PharmaceuticalsAbby Lombardi
 
Total quality management
Total quality managementTotal quality management
Total quality managementAshwin Yadav
 
BIO Windhover Pharmaceutical Strategic Alliances Conference April 2011
BIO Windhover Pharmaceutical Strategic Alliances Conference April 2011BIO Windhover Pharmaceutical Strategic Alliances Conference April 2011
BIO Windhover Pharmaceutical Strategic Alliances Conference April 2011Nathan White, CPC
 
Medi Pragma 2012
Medi Pragma  2012Medi Pragma  2012
Medi Pragma 2012Medi-Pragma
 
Upfront Communication Makes for Better Medical Device Manufacturing - Tom Bla...
Upfront Communication Makes for Better Medical Device Manufacturing - Tom Bla...Upfront Communication Makes for Better Medical Device Manufacturing - Tom Bla...
Upfront Communication Makes for Better Medical Device Manufacturing - Tom Bla...marcus evans Network
 
Anthony Presentation DIA Florida Ctd Nov2007
Anthony Presentation DIA Florida Ctd Nov2007Anthony Presentation DIA Florida Ctd Nov2007
Anthony Presentation DIA Florida Ctd Nov2007AKTaylor
 
Program - 5th Annual Biomanufacturing Summit 2013, San Diego
Program - 5th Annual Biomanufacturing Summit 2013, San DiegoProgram - 5th Annual Biomanufacturing Summit 2013, San Diego
Program - 5th Annual Biomanufacturing Summit 2013, San DiegoMark Blendheim
 
Quality 3.0 THE NEXT REVOLUTION
Quality 3.0 THE NEXT REVOLUTIONQuality 3.0 THE NEXT REVOLUTION
Quality 3.0 THE NEXT REVOLUTIONkkukor
 
Hol webinar summary
Hol webinar summaryHol webinar summary
Hol webinar summaryCameron Tew
 

Similar to CMO Quality Oversight & Risk Management, April 2011, Boston (20)

ACP Fact Sheet
ACP Fact SheetACP Fact Sheet
ACP Fact Sheet
 
Logi Pharma 2010
Logi Pharma 2010Logi Pharma 2010
Logi Pharma 2010
 
Pre Filled Syringes Asia Pacific
Pre Filled Syringes Asia PacificPre Filled Syringes Asia Pacific
Pre Filled Syringes Asia Pacific
 
Barry D. Schwartz, Ph.D.
Barry D. Schwartz, Ph.D.Barry D. Schwartz, Ph.D.
Barry D. Schwartz, Ph.D.
 
"10th Contract Manufacturing for Pharmaceuticals and Biotech Conference
"10th Contract Manufacturing for Pharmaceuticals and Biotech Conference"10th Contract Manufacturing for Pharmaceuticals and Biotech Conference
"10th Contract Manufacturing for Pharmaceuticals and Biotech Conference
 
Shamisha corporate presentation 10112016
Shamisha corporate presentation   10112016Shamisha corporate presentation   10112016
Shamisha corporate presentation 10112016
 
Tbi Bioprocessing Services Sept 25.08
Tbi Bioprocessing Services Sept 25.08Tbi Bioprocessing Services Sept 25.08
Tbi Bioprocessing Services Sept 25.08
 
PharmaForce 2012 Agenda
PharmaForce 2012 AgendaPharmaForce 2012 Agenda
PharmaForce 2012 Agenda
 
Resume Maria Santana
Resume Maria SantanaResume Maria Santana
Resume Maria Santana
 
7th Cold Chain Distribution for Pharmaceuticals
7th Cold Chain Distribution for Pharmaceuticals7th Cold Chain Distribution for Pharmaceuticals
7th Cold Chain Distribution for Pharmaceuticals
 
Med_Man_H1_Del
Med_Man_H1_DelMed_Man_H1_Del
Med_Man_H1_Del
 
Total quality management
Total quality managementTotal quality management
Total quality management
 
BIO Windhover Pharmaceutical Strategic Alliances Conference April 2011
BIO Windhover Pharmaceutical Strategic Alliances Conference April 2011BIO Windhover Pharmaceutical Strategic Alliances Conference April 2011
BIO Windhover Pharmaceutical Strategic Alliances Conference April 2011
 
Medi Pragma 2012
Medi Pragma  2012Medi Pragma  2012
Medi Pragma 2012
 
Upfront Communication Makes for Better Medical Device Manufacturing - Tom Bla...
Upfront Communication Makes for Better Medical Device Manufacturing - Tom Bla...Upfront Communication Makes for Better Medical Device Manufacturing - Tom Bla...
Upfront Communication Makes for Better Medical Device Manufacturing - Tom Bla...
 
Anthony Presentation DIA Florida Ctd Nov2007
Anthony Presentation DIA Florida Ctd Nov2007Anthony Presentation DIA Florida Ctd Nov2007
Anthony Presentation DIA Florida Ctd Nov2007
 
Program - 5th Annual Biomanufacturing Summit 2013, San Diego
Program - 5th Annual Biomanufacturing Summit 2013, San DiegoProgram - 5th Annual Biomanufacturing Summit 2013, San Diego
Program - 5th Annual Biomanufacturing Summit 2013, San Diego
 
Quality 3.0 THE NEXT REVOLUTION
Quality 3.0 THE NEXT REVOLUTIONQuality 3.0 THE NEXT REVOLUTION
Quality 3.0 THE NEXT REVOLUTION
 
Vince Amormino Resume MGMT and MKTG 1 248 467 4800 emailvincenow@gmail.com
Vince Amormino Resume MGMT and MKTG 1 248 467 4800 emailvincenow@gmail.com   Vince Amormino Resume MGMT and MKTG 1 248 467 4800 emailvincenow@gmail.com
Vince Amormino Resume MGMT and MKTG 1 248 467 4800 emailvincenow@gmail.com
 
Hol webinar summary
Hol webinar summaryHol webinar summary
Hol webinar summary
 

More from ExL Pharma

9th Medical Science Liaison Best Practices
9th Medical Science Liaison Best Practices9th Medical Science Liaison Best Practices
9th Medical Science Liaison Best PracticesExL Pharma
 
13th Investigator Initiated Trials, April 2011, Basking Ridge, NJ
13th Investigator Initiated Trials, April 2011, Basking Ridge, NJ13th Investigator Initiated Trials, April 2011, Basking Ridge, NJ
13th Investigator Initiated Trials, April 2011, Basking Ridge, NJExL Pharma
 
2nd Annual Proactive GCP Compliance, April 2011, Arlington, VA
2nd Annual Proactive GCP Compliance, April 2011, Arlington, VA2nd Annual Proactive GCP Compliance, April 2011, Arlington, VA
2nd Annual Proactive GCP Compliance, April 2011, Arlington, VAExL Pharma
 
The 3rd Annual Digital Pharma Europe, March 2011, Ingelheim, Germany
The 3rd Annual Digital Pharma Europe, March 2011, Ingelheim, GermanyThe 3rd Annual Digital Pharma Europe, March 2011, Ingelheim, Germany
The 3rd Annual Digital Pharma Europe, March 2011, Ingelheim, GermanyExL Pharma
 
6th Annual Support for Independent Medical Education, March 2011, New York City
6th Annual Support for Independent Medical Education, March 2011, New York City6th Annual Support for Independent Medical Education, March 2011, New York City
6th Annual Support for Independent Medical Education, March 2011, New York CityExL Pharma
 
5th Forecasting and Optimizing the Clinical Supply Chain, March 2011, Philade...
5th Forecasting and Optimizing the Clinical Supply Chain, March 2011, Philade...5th Forecasting and Optimizing the Clinical Supply Chain, March 2011, Philade...
5th Forecasting and Optimizing the Clinical Supply Chain, March 2011, Philade...ExL Pharma
 
4th Lean Sigma & Kaizen for Pharma R&D Conference, March 2011, Miami
4th Lean Sigma & Kaizen for Pharma R&D Conference, March 2011, Miami4th Lean Sigma & Kaizen for Pharma R&D Conference, March 2011, Miami
4th Lean Sigma & Kaizen for Pharma R&D Conference, March 2011, MiamiExL Pharma
 
6th Clinical Data Disclosure Summit, March 2011, Philadelphia
6th Clinical Data Disclosure Summit, March 2011, Philadelphia6th Clinical Data Disclosure Summit, March 2011, Philadelphia
6th Clinical Data Disclosure Summit, March 2011, PhiladelphiaExL Pharma
 
2nd Annual Clinical Site Feasibility, Selection, and Startup, March 2011, Phi...
2nd Annual Clinical Site Feasibility, Selection, and Startup, March 2011, Phi...2nd Annual Clinical Site Feasibility, Selection, and Startup, March 2011, Phi...
2nd Annual Clinical Site Feasibility, Selection, and Startup, March 2011, Phi...ExL Pharma
 
6th Latin America Clinical Trials Conference, March 2011, Philadelphia
6th Latin America Clinical Trials Conference, March 2011, Philadelphia6th Latin America Clinical Trials Conference, March 2011, Philadelphia
6th Latin America Clinical Trials Conference, March 2011, PhiladelphiaExL Pharma
 
2nd Patient Engagement Summit: New Technologies for Engaging Patients in Clin...
2nd Patient Engagement Summit: New Technologies for Engaging Patients in Clin...2nd Patient Engagement Summit: New Technologies for Engaging Patients in Clin...
2nd Patient Engagement Summit: New Technologies for Engaging Patients in Clin...ExL Pharma
 
Highlights from ExL Pharma's 12th Investigator Initiated Trials
Highlights from ExL Pharma's 12th Investigator Initiated TrialsHighlights from ExL Pharma's 12th Investigator Initiated Trials
Highlights from ExL Pharma's 12th Investigator Initiated TrialsExL Pharma
 
Highlights from ExL Pharma's 6th MSL Best Practices
Highlights from ExL Pharma's 6th MSL Best PracticesHighlights from ExL Pharma's 6th MSL Best Practices
Highlights from ExL Pharma's 6th MSL Best PracticesExL Pharma
 
Highlights from ExL Pharma's Proactive GCP Compliance
Highlights from ExL Pharma's Proactive GCP ComplianceHighlights from ExL Pharma's Proactive GCP Compliance
Highlights from ExL Pharma's Proactive GCP ComplianceExL Pharma
 
Highlights from ExL Pharma's 3rd Lean Sigma & Kaizen
Highlights from ExL Pharma's 3rd Lean Sigma & KaizenHighlights from ExL Pharma's 3rd Lean Sigma & Kaizen
Highlights from ExL Pharma's 3rd Lean Sigma & KaizenExL Pharma
 
Highlights from ExL Pharma's 2nd Digital Pharma Europe
Highlights from  ExL Pharma's 2nd Digital Pharma EuropeHighlights from  ExL Pharma's 2nd Digital Pharma Europe
Highlights from ExL Pharma's 2nd Digital Pharma EuropeExL Pharma
 
Highlights from ExL Pharma's 4th Clinical Billing & Research Compliance
Highlights from ExL Pharma's 4th Clinical Billing & Research ComplianceHighlights from ExL Pharma's 4th Clinical Billing & Research Compliance
Highlights from ExL Pharma's 4th Clinical Billing & Research ComplianceExL Pharma
 
Highlights from ExL Pharma's 5th Data Monitoring Committees
Highlights from ExL Pharma's 5th Data Monitoring CommitteesHighlights from ExL Pharma's 5th Data Monitoring Committees
Highlights from ExL Pharma's 5th Data Monitoring CommitteesExL Pharma
 
Highlights from ExL Pharma's Site Selection, Activation & Communication
Highlights from ExL Pharma's Site Selection, Activation & CommunicationHighlights from ExL Pharma's Site Selection, Activation & Communication
Highlights from ExL Pharma's Site Selection, Activation & CommunicationExL Pharma
 
Highlights from ExL Pharma's 4th Latin America Clinical Trials
Highlights from  ExL Pharma's 4th Latin America Clinical TrialsHighlights from  ExL Pharma's 4th Latin America Clinical Trials
Highlights from ExL Pharma's 4th Latin America Clinical TrialsExL Pharma
 

More from ExL Pharma (20)

9th Medical Science Liaison Best Practices
9th Medical Science Liaison Best Practices9th Medical Science Liaison Best Practices
9th Medical Science Liaison Best Practices
 
13th Investigator Initiated Trials, April 2011, Basking Ridge, NJ
13th Investigator Initiated Trials, April 2011, Basking Ridge, NJ13th Investigator Initiated Trials, April 2011, Basking Ridge, NJ
13th Investigator Initiated Trials, April 2011, Basking Ridge, NJ
 
2nd Annual Proactive GCP Compliance, April 2011, Arlington, VA
2nd Annual Proactive GCP Compliance, April 2011, Arlington, VA2nd Annual Proactive GCP Compliance, April 2011, Arlington, VA
2nd Annual Proactive GCP Compliance, April 2011, Arlington, VA
 
The 3rd Annual Digital Pharma Europe, March 2011, Ingelheim, Germany
The 3rd Annual Digital Pharma Europe, March 2011, Ingelheim, GermanyThe 3rd Annual Digital Pharma Europe, March 2011, Ingelheim, Germany
The 3rd Annual Digital Pharma Europe, March 2011, Ingelheim, Germany
 
6th Annual Support for Independent Medical Education, March 2011, New York City
6th Annual Support for Independent Medical Education, March 2011, New York City6th Annual Support for Independent Medical Education, March 2011, New York City
6th Annual Support for Independent Medical Education, March 2011, New York City
 
5th Forecasting and Optimizing the Clinical Supply Chain, March 2011, Philade...
5th Forecasting and Optimizing the Clinical Supply Chain, March 2011, Philade...5th Forecasting and Optimizing the Clinical Supply Chain, March 2011, Philade...
5th Forecasting and Optimizing the Clinical Supply Chain, March 2011, Philade...
 
4th Lean Sigma & Kaizen for Pharma R&D Conference, March 2011, Miami
4th Lean Sigma & Kaizen for Pharma R&D Conference, March 2011, Miami4th Lean Sigma & Kaizen for Pharma R&D Conference, March 2011, Miami
4th Lean Sigma & Kaizen for Pharma R&D Conference, March 2011, Miami
 
6th Clinical Data Disclosure Summit, March 2011, Philadelphia
6th Clinical Data Disclosure Summit, March 2011, Philadelphia6th Clinical Data Disclosure Summit, March 2011, Philadelphia
6th Clinical Data Disclosure Summit, March 2011, Philadelphia
 
2nd Annual Clinical Site Feasibility, Selection, and Startup, March 2011, Phi...
2nd Annual Clinical Site Feasibility, Selection, and Startup, March 2011, Phi...2nd Annual Clinical Site Feasibility, Selection, and Startup, March 2011, Phi...
2nd Annual Clinical Site Feasibility, Selection, and Startup, March 2011, Phi...
 
6th Latin America Clinical Trials Conference, March 2011, Philadelphia
6th Latin America Clinical Trials Conference, March 2011, Philadelphia6th Latin America Clinical Trials Conference, March 2011, Philadelphia
6th Latin America Clinical Trials Conference, March 2011, Philadelphia
 
2nd Patient Engagement Summit: New Technologies for Engaging Patients in Clin...
2nd Patient Engagement Summit: New Technologies for Engaging Patients in Clin...2nd Patient Engagement Summit: New Technologies for Engaging Patients in Clin...
2nd Patient Engagement Summit: New Technologies for Engaging Patients in Clin...
 
Highlights from ExL Pharma's 12th Investigator Initiated Trials
Highlights from ExL Pharma's 12th Investigator Initiated TrialsHighlights from ExL Pharma's 12th Investigator Initiated Trials
Highlights from ExL Pharma's 12th Investigator Initiated Trials
 
Highlights from ExL Pharma's 6th MSL Best Practices
Highlights from ExL Pharma's 6th MSL Best PracticesHighlights from ExL Pharma's 6th MSL Best Practices
Highlights from ExL Pharma's 6th MSL Best Practices
 
Highlights from ExL Pharma's Proactive GCP Compliance
Highlights from ExL Pharma's Proactive GCP ComplianceHighlights from ExL Pharma's Proactive GCP Compliance
Highlights from ExL Pharma's Proactive GCP Compliance
 
Highlights from ExL Pharma's 3rd Lean Sigma & Kaizen
Highlights from ExL Pharma's 3rd Lean Sigma & KaizenHighlights from ExL Pharma's 3rd Lean Sigma & Kaizen
Highlights from ExL Pharma's 3rd Lean Sigma & Kaizen
 
Highlights from ExL Pharma's 2nd Digital Pharma Europe
Highlights from  ExL Pharma's 2nd Digital Pharma EuropeHighlights from  ExL Pharma's 2nd Digital Pharma Europe
Highlights from ExL Pharma's 2nd Digital Pharma Europe
 
Highlights from ExL Pharma's 4th Clinical Billing & Research Compliance
Highlights from ExL Pharma's 4th Clinical Billing & Research ComplianceHighlights from ExL Pharma's 4th Clinical Billing & Research Compliance
Highlights from ExL Pharma's 4th Clinical Billing & Research Compliance
 
Highlights from ExL Pharma's 5th Data Monitoring Committees
Highlights from ExL Pharma's 5th Data Monitoring CommitteesHighlights from ExL Pharma's 5th Data Monitoring Committees
Highlights from ExL Pharma's 5th Data Monitoring Committees
 
Highlights from ExL Pharma's Site Selection, Activation & Communication
Highlights from ExL Pharma's Site Selection, Activation & CommunicationHighlights from ExL Pharma's Site Selection, Activation & Communication
Highlights from ExL Pharma's Site Selection, Activation & Communication
 
Highlights from ExL Pharma's 4th Latin America Clinical Trials
Highlights from  ExL Pharma's 4th Latin America Clinical TrialsHighlights from  ExL Pharma's 4th Latin America Clinical Trials
Highlights from ExL Pharma's 4th Latin America Clinical Trials
 

CMO Quality Oversight & Risk Management, April 2011, Boston

  • 1. REGISTER BY FeBruary 25 AND SAVE $400! CMo Quality oversight & risk ManageMent Managing CMOs to Deliver Your Product to Your Quality & Time Requirements April 28th – 29th, 2011, Omni Parker House Hotel, Boston MA Featured Presentations: sPeaking FaCulty regulatory Perspective on Quality assurance within the evolving dhan amaria, Director, Quality Assurance, Contract Manufacturing relationship NEKTAR THERAPEUTICS sandra roque, Director, Manufacturing QA, NOVEN PHARMACEUTICALS rhonda Fendelet, Director, External Supply Integration Quality – PDMS, JANSSEN SUPPLY CHAIN applying a risk Management system to the Contracting Process rolf hartmann, Procurement Director, to sustain the highest level of Quality from a CMo/sponsor GLAXOSMITHKLINE relationship Juanita hawkins, Vice President, Global Caroline o’Brien, Associate Director QA Sourcing, Pharmaceutical Quality Assurance and Compliance, CELGENE Development, ASTRAZENECA Jeff huth, Ph.d., Leader, Quality & Compliance, JANSSEN ALZHEIMER IMMUNOTHERAPY RESEARCH & how overall Product lifecycle and Product Phases including DEVELOPMENT Commercialization Can Factor into the Contract Manufacturing denise Mcdade, Senior Director, Quality relationship Assurance, AMYLIN PHARMACEUTICALS Jeff huth, Ph.d., Leader, Quality & Compliance, robert o’hagan, Director Quality Operations, JANSSEN ALZHEIMER IMMUNOTHERAPY RESEARCH & DEVELOPMENT ABBOTT BIORESEARCH CENTER Caroline o’Brien, Associate Director QA Sourcing, Pharmaceutical Development, ASTRAZENECA Featured Panel disCussion: sandra roque, Director, Manufacturing QA, NOVEN PHARMACEUTICALS global Considerations and Business differences when Contracting Prashant savle, Ph.d., Director, Sourcing, an off-shore CMo Partner: how Close are We to a harmonized Global Procurement, MERCK SHARPE & DOHME standard of gMP? Michael semo, Global Sourcing Manager, Virtual Panelists: CMC Team, ELI LILLY & COMPANY Prashant savle, Ph.d., Director, Sourcing, Global Procurement, MERCK SHARPE & DOHME g. sean Williams C.P.M., sCor-P, Associate Dir, Global Facilities Procurement, Michael semo, Global Sourcing Manager, Virtual CMC Team, BRISTOL-MYERS SQUIBB ELI LILLY & COMPANY Janice B Wilson, Phd, Vice President dhan amaria, Director, Quality Assurance, NEKTAR THERAPEUTICS Corporate Quality Assurance, ELAN PHARMACEUTICALS To R e gister Call 866-207-6528 or visit www.exlpharma.com/ c m o
  • 2. Dear Colleague, This Summit is specifically designed for C-Levels, Department There is industry agreement that a substantial investment must be made to Heads, Vice Presidents, Directors support the life-cycle of a pharmaceutical product from the developmental stage and Managers at pharmaceutical, to commercial production. There is also definitive data that shows in addition to biotechnology and medical device the FDA, regulatory bodies worldwide are becoming more and more conservative companies from the following with the candidates they approve for commercial access. departments: Within the contract manufacturing relationship, pharmaceutical companies are taking the necessary steps to adjust to this changing industry trend, providing  Contract manufacturing increased resources to ensure control and consistency in the manufacturing of  manufacturing Operations their products to avoid unnecessary delays including regulatory action.  Regulatory Affairs Join us April 28th - 29th where presentations dedicated to the successful CMO  Regulatory Compliance partnership dynamic will be shared, including best practices in management such  Validation as quality oversight, risk management, and ensuring time requirements are met.  Compliance The FDA has made it clear that if your name is on the label, you are responsible  Quality Assurance for what’s inside the package.  Quality Operations Look forward to seeing you in Boston!  Quality Development  Outsourcing Sincerely,  Sourcing  Supply Chain  Operational Excellence Matthew Millman Senior Conference Director mmillman@exlpharma.com Sponsorship and Exhibit Opportunities OmNI PARkER HOuSE HOTEl Do you want to spread the word about your organization’s solutions 60 School Street and services to potential clients who Boston, MA 02108 attend this event? Take advantage of P:617-227-8600 the opportunity to exhibit, present an educational session, host a networking event, or distribute promotional items to attendees. ExL works closely with you As you pass through the sculpted bronze doors of this luxury Boston hotel, you to customize a package that suits all of will be enveloped by the timeless beauty that has made the Omni Parker House your needs. a landmark since 1855. Experience the perfect blend of modern amenities and historic charm at America’s oldest continuously-operating hotel. Walk to Beacon To learn more about these opportunities, Hill, Faneuil Hall Marketplace, Quincy Market, the Financial District, shopping and contact Eric Morrin, Business more. Just 2.5 miles (10-15 minutes) from Logan International Airport. Development Manager by calling 212-400-6228 or by emailing room reservations: If you require overnight accommodations, please contact the hotel and state that you are with ExL’s CMO Quality Oversight & Risk Management Conference for emorrin@exlpharma.com. information on our discounted room rates. We encourage conference participants to make reservations by Wednesday, April 6th with our designated venue as our discounted room rates are limited. To R e g i ster Call 866-207-6528 or visit www.exlpharma.com/c m o
  • 3. day one – aPril 28th, 2011 Pre-ConFerenCe WorkshoP 8:00 Registration Opens and Continental Breakfast is Served for Workshop Attendees 9:00 selecting a CMo Partner How Including Quality Early in the Selection Process can Ensure a Stronger Overall Partnership Led By: Janice B Wilson, PhD, Vice President Corporate Quality Assurance, ELAN PHARMACEUTICALS • Including quality in the selection process - Transparency and accessibility of a potential partners’ quality history - What quality factors to look for from a partner - What issues can kill the deal? • Designing quality agreements with clear criteria that define the responsibilities of an outsourced partner - Identifying the important deliverables that need to be included in the Quality Agreement - Customizing a Quality Agreement that fits a specific project aspect - Determining which types of agreements to use – technical versus quality? What is the difference? - Modifying a Quality Agreement to reflect existing regulations and industry standards *There will be a 30-minute coffee and networking break during the workshop 12:00 Lunch for Workshop Attendees / Registration Opens for Main Conference Main ConFerenCe 3:00 networking & refreshment Break 1:15 Chairperson’s Welcome and Opening Remarks 3:30 Case study: integrated Facilities 1:30 keynote talk: CMo Management outsourcing ManageMent strategy Thinking with the End in Mind: Driving a Streamlined Global Integrated Facilities Management Outsourcing Deal from Concept Aligning Your Corporate Philosophy and Your CMO Outsourcing to Implementation Strategy to Achieve Business Objectives G. Sean Williams C.P.M., SCOR-P Associate Dir, Global Facilities Juanita Hawkins, Vice President, Global Quality Assurance and Procurement, BRISTOL-MYERS SQUIBB Compliance, CELGENE • Evaluating the pros and cons to understand whether an IFM program fits into your • Gaining internal buy-in and understanding the risk related to strategy company’s strategic planning • Critical decision making for internal, external or hybrid manufacturing allocation • Building the appropriate quality and performance measurements in the negotiation • Clarity for expectations, delegating work versus responsibility, and control to prevent post implementation margin erosion • Key drivers of Service Provider downselecting outside of cost 2:15 regulatory Perspective 4:15 Communication The Roadmap for Successful Communication within a Partnership that Regulatory Perspective on Quality Assurance within the Drives Quality Oversight Success Evolving Contract Manufacturing Relationship Rhonda Fendelet, Director, External Supply Integration Quality – PDMS, Sandra Roque, Director, Manufacturing QA, NOVEN PHARMACEUTICALS JANSSEN SUPPLY CHAIN • Agency concerns over business procedures • The governance model and deployment of Communication Plan • Expectations for both sponsors and contract sites during inspections and GMP • Clarifying roles & responsibilities within the relationship to avoid dysfunction assessments • Using metrics and feedback as the key performance indicators for success • Best practices to ensure that sponsors, contract manufacturers and regulatory agencies are all on the same page • Upcoming anticipated guidance for selection of a contract facility and conducting audits 5:00 Close of day one To R e g i ster Call 866-207-6528 or visit www.exlpharma.com/c m o
  • 4. day tWo – aPril 29th, 2011 international Considerations Main ConFerenCe 11:45 PANEL DISCUSSION: Global Considerations and Business Differences when Contracting an Off-Shore CMO Partner: How Close are We to 9:00 Chairperson’s Day Two Welcome and a Harmonized Standard of GMP? Opening Remarks Panelists Include: Dhan Amaria, Director, Quality Assurance, NEKTAR THERAPEUTICS Prashant S Savle, Ph.D., Director, Sourcing, Global Procurement, 9:05 lifecycle Considerations MERCK SHARPE & DOHME Michael Semo, Global Sourcing Manager, Virtual CMC Team, How Overall Product Lifecycle and Product Phases Including ELI LILLY & COMPANY Commercialization Can Factor into the Contract Manufacturing • What are the differences between a domestic partner and an international Relationship one, if any? Jeff Huth, Ph.D., Leader, Quality & Compliance, • What cultural considerations should be made prior to commencement of the JANSSEN ALZHEIMER IMMUNOTHERAPY RESEARCH & DEVELOPMENT partnership and how do these affect the level of communication and expectations? Contract Manufacturing Organizations face an evolutionary dilemma in trying to • How does risk acceptability vary between a sponsor and a contract partner? establish their business plan strategy and technical capabilities every day. While clearly there is a capital investment consideration in this regard, there are also key technical, operational, and regulatory considerations. 12:30 lunch This Session will Examine: • Elements associated with pharmaceutical product life-cycle as they relate to the technical, operational, and regulatory issues 1:30 Metrics • Discussion on the significance of the partnerships required to successfully manage Using KPIs and Operational Excellence to Ensure Quality in an the evolutionary pharmaceutical product life-cycle Outsourced Supply Chain • How ICH guidance concepts (in particular, ICH Q10) can provide a platform to not Denise McDade, Senior Director, Quality Assurance, only manage the relationship, but to enhance it. AMYLIN PHARMACEUTICALS • Setting quality oversight standards that drive the level of performance measurement and data collection • Building a corporate culture that can create a strategy to meet the standards 9:45 risk Management necessary for quality excellence Applying a Risk Management System to Vendor Assurance and Supplier • Adopting risk-shared principles that extend accountability to a project-wide scope Management in Development Caroline O’Brien, Associate Director QA Sourcing, Pharmaceutical 2:15 aPi development Development, ASTRAZENECA Keys for Successful Contract Manufacturing of Biological API’s to • Clearly and thoroughly translating risk factors for materials, processes and suppliers Support Clinical and Commercial Material • Understanding of Supply Chain and application of risk managed supplier auditing Robert O’Hagan, Director Quality Operations, • Development and maintenance of the holistic approach to Supplier Management ABBOTT BIORESEARCH CENTER • CMO Selection Considerations • Successful Business Model for CMO through product lifecycle 10:30 networking & refreshment Break • Quality Agreements and Regulatory Considerations 3:00 Closing Panel disCussion: 11:00 spotlight session: outsourcing and Decommissions, Facing Problems, and Accepting that the Partnership Quality in latin america is Faulty – What Should be Done to Minimize the Failure Considerations when Contracting a CMO Partner in Latin America: Featuring Conference Presenters Regional Benefits & Constraints • What are the initial steps to be taken once a partnership is disconnected? Rolf Hartmann, Procurement Director, GLAXOSMITHKLINE • How to calculate the financial implications from the missteps that have occurred? • Examining cost differences between CMOs in Latin America and other Regions • Determine what the consequences are and if they can be fixed? • Ensuring quality standards and regulatory requirements are met and kept when • What are the public and reputational damage that has been done? working with an international CMO • Latin America regional snap-shot: contracting in traditional versus non-traditional countries 3:45 Close of Conference To R e g i ster Call 866-207-6528 or visit www.exlpharma.com/c m o
  • 5. Five Ways to register RegistRation Fees FoR attending exl’s CMo Quality oversight & PHOnE: 866-207-6528 risk ManageMent ConFeRenCe: EMAIL: register@exlpharma.com OnLInE: www.exlpharma.com Best value REgISTER By FRIDAy, FEBRuARy 25TH AnD SAvE $400! FAx: 888-221-6750 COnFEREnCE + WORkSHOP | $1795 MAIL: ExL Events, Inc. COnFEREnCE OnLy | $1495 555 8th Ave, Ste 310 new york, ny 10018 early-Bird PriCing REgISTER By FRIDAy, MARCH 25TH TO TAkE ADvAnTAgE OF EARLy-BIRD PRICIng: Group Discount proGram: COnFEREnCE + WORkSHOP | $1995 COnFEREnCE OnLy | $1695 save 25% Per Person When registering Four For every three simultaneous registrations from your company, you will receive a fourth complimentary standard PriCing registration to the program (must register 4 at one REgISTER AFTER MARCH 25TH: time). this is a savings of 25% per person. COnFEREnCE + WORkSHOP | $2195 save 15% Per Person When registering three COnFEREnCE OnLy | $1895 Can only send three? You can still save 15% off of every registration. to find out more on how you can visit WWW.exlPharMa.CoM/CMo take advantage of these group discounts, please call TO VIEw OuR VAluE JuSTIfICATION DOCumENT! 866-207-6528. Make checks payable to exl events, inc. and write code mEDIA PARTNERS P742 on your check. You may also use Visa, MasterCard, discover or american express. Payments must be received in full 2 weeks prior to the conference. Cancellations: if you need to cancel your registration for an upcoming exL conference, please note the following policies derived from the start date of the event: • Four weeks or more: a full refund (minus a $95 processing fee), or a voucher to another exL event valid for two years from the voucher issue date Four weeks or less: a voucher to another exL event valid for two years from the voucher issue date. • to receive a refund or voucher, please fax your request to 888-221-6750. • there will be an administrative charge of $300 to substitute, exchange and/or replace attendance badges with a colleague occurring within five business days of the conference. Please Note: Speakers and agenda are subject to change without notice. In the event of a speaker cancellation, every effort to find a suitable replacement will be made. ExL Pharma’s liability is limited to the conference registration fee in the event of a cancellation *The opinions of this faculty do not necessarily reflect those of the companies they represent or ExL Events, Inc.* QuESTIONS? COmmENTS? do you have a question or comments that you would like to be addressed at this event? Would you like to get involved as a speaker or discussion leader? Please email Conference director, Matt Millman at mmillman@exlpharma.com
  • 6. Fax: Telephone: Email: Zip: State: City: Address: Dept.: Company: Title: Name: PLEASE MENTION PRIORITY CODE: P742  I wish to receive email updates on ExL Pharma’s upcoming events New York, NY 10018  I’m interested in marketing opportunities at this event 555 8th Avenue, Suite 310 Please contact me: Yes! Register me for the conference only  Signature: Yes! Register me for the conference and workshop:  Name on Card: www.exlpharma.com/cmo Exp. Date: Card Number: registration@exlpharma.com New York, NY 10018 MasterCard  Visa  Discover Amex Card Type: 888-221-6750 555 8th Avenue, Suite 310 Make checks payable to ExL Events, Inc. 866-207-6528 ExL Events, Inc.  Check Credit Card Method of Payment: Registration Form: REGISTER BY FeBruary 25 AND SAVE $400! CMo Quality oversight & risk ManageMent Managing CMOs to Deliver Your Product to Your Quality & Time Requirements April 28th – 29th, 2011, Omni Parker House Hotel, Boston MA Featured Presentations: sPeaking FaCulty FroM these CoMPanies Regulatory Perspective on Quality Assurance How Overall Product lifecycle and Product Phases within the Evolving Contract manufacturing Including Commercialization Can factor into the NEKTAR THERAPEUTICS NOVEN Relationship Contract manufacturing Relationship PHARMACEUTICALS MERCK ELI LILLY & COMPANY Applying a Risk management System to the Global Considerations and Business Differences GLAXOSMITHKLINE Contracting Process to Sustain the Highest level of when Contracting an Off-Shore CmO Partner: How BRISTOL-MYERS SQUIBB CELGENE Quality from a CmO/Sponsor Relationship Close are we to a Harmonized Standard of GmP? ELAN ASTRAZENECA PHARMACEUTICALS To R e gister Call 866-207-6528 or visit www.exlpharma.com/ c m o